Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;23(1, Cerebrovascular Disease):133-157.
doi: 10.1212/CON.0000000000000436.

Large Artery Atherosclerotic Occlusive Disease

Review

Large Artery Atherosclerotic Occlusive Disease

John W Cole. Continuum (Minneap Minn). 2017 Feb.

Abstract

Purpose of review: Extracranial or intracranial large artery atherosclerosis is often identified as a potential etiologic cause for ischemic stroke and transient ischemic attack. Given the high prevalence of large artery atherosclerosis in the general population, determining whether an identified atherosclerotic lesion is truly the cause of a patient's symptomatology can be difficult. In all cases, optimally treating each patient to minimize future stroke risk is paramount. Extracranial or intracranial large artery atherosclerosis can be broadly compartmentalized into four distinct clinical scenarios based upon the individual patient's history, examination, and anatomic imaging findings: asymptomatic and symptomatic extracranial carotid stenosis, intracranial atherosclerosis, and extracranial vertebral artery atherosclerotic disease. This review provides a framework for clinicians evaluating and treating such patients.

Recent findings: Intensive medical therapy achieves low rates of stroke and death in asymptomatic carotid stenosis. Evidence indicates that patients with severe symptomatic carotid stenosis should undergo carotid revascularization sooner rather than later and that the risk of stroke or death is lower using carotid endarterectomy than with carotid stenting. Specific to stenting, the risk of stroke or death is greatest among older patients and women. Continuous vascular risk factor optimization via sustained behavioral modifications and intensive medical therapy is the mainstay for stroke prevention in the setting of intracranial and vertebral artery origin atherosclerosis.

Summary: Lifelong vascular risk factor optimization via sustained behavioral modifications and intensive medical therapy are the key elements to reduce future stroke risk in the setting of large artery atherosclerosis. When considering a revascularization procedure for carotid stenosis, patient demographics, comorbidities, and the periprocedural risks of stroke and death should be carefully considered.

PubMed Disclaimer

Figures

FIGURE 7-1
FIGURE 7-1
FIGURE 7-2
FIGURE 7-2
FIGURE 7-3
FIGURE 7-3

References

    1. Gounis MJ, van der Marel K, Marosfoi M, et al. Imaging inflammation in cerebrovascular disease. Stroke 2015;46(10):2991–2997. doi:10.1161/STROKEAHA.115.008229. - PMC - PubMed
    1. CDC 2013. Detailed Tables for the National Vital Statistics Report (NVSR) “Deaths: Final Data for 2013.”, authors. cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf. Published February 16, 2016. Accessed December 6, 2016.
    1. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45(12):3754–3832. doi:10.1161/STR.0000000000000046. - PMC - PubMed
    1. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45(7):2160–2236. doi:10.1161/STR.0000000000000024. - PubMed
    1. Spence JD. Management of patients with an asymptomatic carotid stenosis—medical management, endovascular treatment, or carotid endarterectomy? Curr Neurol Neurosci Rep 2016;16(1):3 doi:10.1007/s11910–015–0605–6. - PubMed